SLT Photoregeneration

To manage the intraocular pressure associated with open angle glaucoma, Ellex offers two Selective Laser Trabeculoplasty (SLT) systems: Tango and Solo. SLT uses low energy light to target and irradiate melanin-rich cells in the trabecular meshwork without affecting the surrounding structure. In response, the body automatically rebuilds the meshwork, which increases aqueous outflow, restores normal function and reduces intraocular pressure.

SLT is repeatable, gentle and non-invasive, and can be considered a primary treatment option for patients who cannot tolerate or are unable to self-administer glaucoma medications. It can also be used in conjunction with traditional drug therapy. There are no risks, complications or side effects, such as the burn and scar tissue associated with other laser procedures.

Solo

The Ellex Solo is a solid-state ophthalmic laser system designed specifically for selective laser trabeculoplasty (SLT), which is an advanced, non-invasive surgical approach for stimulating the generation of healthy trabecular meshwork cells and managing intraocular pressure. This repeatable, non-invasive treatment promotes cellular regeneration without the burn and scar tissue associated with other laser procedures.

Tango

The Ellex Tango provides selective laser trabeculoplasty (SLT) and photodisruptor capabilities in a single, advanced laser system. Its SLT mode delivers an advanced, non-invasive surgical approach for stimulating the generation of healthy trabecular meshwork cells and managing intraocular pressure. This repeatable, non-invasive treatment promotes cellular regeneration without the burn and scar tissue associated with other laser procedures. The Tango's photodisruptor mode provides optimized, ultra-low energy optical breakdown for capsulotomy and iridotomy procedures. The Tango features a proprietary dual mode laser cavity integrated into the slit lamp to ensure efficient delivery of laser energy and maintain stable alignment.

Request a Demo

SLT Treatment Information Clinical Applications of SLT Selective Photoregeneration is an unprecedented option for lowering intraocular pressure (IOP) by activating a cellular level response that results in restored function of the trabecular meshwork. Highly effective, SLT is used as a primary treatment option for early stages of open angle glaucoma, and can be used in combination with drug therapy or as an alternative therapy when drugs fail. It is also a flexible treatment option, given that it can be repeatedl if necessary, depending on the individual patient's response.
SLT and Open-Angle Glaucoma (OAG) SLT is a non-thermal treatment which uses short pulses of relatively low energy 532 nm light to target and irradiate only the melanin-rich cells in the TM. The laser pulses affect only these melanin-containing cells, and the surrounding structure of the TM is unaffected. During the procedure approximately 50 confluent spots are applied along the meshwork in order to treat a 180° angle. This gentle laser treatment induces an automatic response from the body in which macrophages are released to clear the affected cells and rebuild the meshwork so that it again functions effectively, thus reducing IOP. SLT effectively lowers elevated IOP without the side effects and compliance issues associated with drug therapy. SLT is particularly appropriate for individuals who cannot correctly administer, or are intolerant to, glaucoma medications, and can also be used in conjunction with medication to enhance the overall IOP-lowering effect.
SLT vs. ALT The SLT technique is much less traumatic to the eye than ALT and retains the therapeutic benefits of laser treatment without causing collateral damage to the TM structure - the short pulse duration of SLT is below the thermal relaxation time of the TM tissue and thereby eliminates the incidence of thermal damage. It has been clinically proven that SLT is as effective as ALT in lowering IOP, and has the additional benefit of enabling re-treatment if required.

SLT Treatment Information

Clinical Applications of SLT

Selective Photoregeneration is an unprecedented option for lowering intraocular pressure (IOP) by activating a cellular level response that results in restored function of the trabecular meshwork. Highly effective, SLT is used as a primary treatment option for early stages of open angle glaucoma, and can be used in combination with drug therapy or as an alternative therapy when drugs fail. It is also a flexible treatment option, given that it can be repeatedl if necessary, depending on the individual patient's response.

SLT and Open-Angle Glaucoma (OAG)

SLT is a non-thermal treatment which uses short pulses of relatively low energy 532 nm light to target and irradiate only the melanin-rich cells in the TM. The laser pulses affect only these melanin-containing cells, and the surrounding structure of the TM is unaffected. During the procedure approximately 50 confluent spots are applied along the meshwork in order to treat a 180° angle. This gentle laser treatment induces an automatic response from the body in which macrophages are released to clear the affected cells and rebuild the meshwork so that it again functions effectively, thus reducing IOP. SLT effectively lowers elevated IOP without the side effects and compliance issues associated with drug therapy. SLT is particularly appropriate for individuals who cannot correctly administer, or are intolerant to, glaucoma medications, and can also be used in conjunction with medication to enhance the overall IOP-lowering effect.

SLT vs. ALT

The SLT technique is much less traumatic to the eye than ALT and retains the therapeutic benefits of laser treatment without causing collateral damage to the TM structure - the short pulse duration of SLT is below the thermal relaxation time of the TM tissue and thereby eliminates the incidence of thermal damage. It has been clinically proven that SLT is as effective as ALT in lowering IOP, and has the additional benefit of enabling re-treatment if required.